Key points

  • Alphatec Holdings, Inc. (ATEC) is down 38.08% to $7.04, leaving the NASDAQ-listed medical device maker with a market capitalisation of $1.09 billion.
  • Volume has reached 27,292,279 shares against a 2,396,581 average, about 11.4 times a normal session.
  • Director David Demski bought 60,000 shares, part of a six-month record of 4 Form 4 open-market purchases worth $2.0 million by 3 insiders, the most recent dated Fri Oct 30 2026.

Shares of Alphatec Holdings, Inc. fell 38.08% to $7.04, one of the sharpest single-day declines in the Medical Devices group. The move takes the stock to within pennies of its 52-week low of $6.81, at the very bottom of a range that tops out at $23.29. Turnover has been extraordinary, with more than 27 million shares changing hands.

What Is Moving Alphatec Holdings, Inc. Today?

The proximate trigger is the company's third quarter 2026 report. Seeking Alpha published the Q3 2026 earnings call presentation roughly nine hours ago, and GuruFocus covered the Q3 2026 earnings call highlights three days back, noting surgeon growth among the themes management put forward. Whatever investors heard in the full disclosure, the price reaction has been severe and one directional.

Layered on top of the results are legal notices. FinancialContent reported about 17 hours ago that Levi & Korsinsky is notifying investors of an investigation into Alphatec Holdings, and PR Newswire carried a similar notice two days ago from SueWallSt regarding potential securities claims. Announcements of this type typically follow a disclosure that disappointed the market, and they tend to keep selling pressure elevated while the facts are unclear.

The mechanics amplify the move. Volume of 27,292,279 shares against a 2,396,581 average is roughly 11.4 times normal, which is the signature of forced repositioning rather than ordinary trading. At a $1.09 billion market capitalisation, Alphatec is a small-cap, and small-caps absorb that kind of flow poorly. The stock now sits about 1% of the way up its 52-week range, against a high of $23.29.

Were Insiders Buying or Selling?

Our own SEC Form 4 database shows buying, and it is recent. Over the last six months, 3 insiders made 4 open-market purchases totalling $2.0 million, with the most recent filing dated Fri Oct 30 2026. The highest profile of those is Director David Demski, whose purchase of 60,000 shares was reported by GuruFocus one day ago. Counting the broader set of recent purchase filings in our record, 5 insider buys total $2.42 million, again with Demski as the most recent name.

Against that, 2 insiders disposed of stock in 2 transactions worth $127,282, the most recent on Wed Aug 05 2026. In dollar terms the selling is a small fraction of the buying.

Open-market buying by directors is a disclosure of fact, not a forecast. It tells a reader that people with a close view of the business committed personal capital at prices set before today's decline. It does not tell a reader why they bought, nor does it offset what the market has priced in today.

Should You Invest in Alphatec Holdings, Inc.?

The data here points in two directions at once. A 38.08% drop to $7.04, sitting just 1% above the 52-week low of $6.81 on 11.4 times average volume, is historically associated with a material change in how the market values a business, and the pending law firm investigations add an unresolved overhang. On the other side, $2.0 million of insider purchases across 4 filings by 3 insiders, the latest on Oct 30 2026, may suggest that some directors saw value above current levels.

Investors may want to monitor the full Q3 2026 disclosures, any company response to the investigation notices, and whether further Form 4 purchases appear at post-decline prices. A single day's move, however large, does not settle the question.